February 22, 2017 5:04 AM ET

Biotechnology

Company Overview of AdvanDx, Inc.

Key Executives for AdvanDx, Inc.

NameBoard RelationshipsTitleAge
Dennis H. Langer M.D., J.D.223 RelationshipsChief Executive Officer and Director64
Henrik Stender Ph.D.15 RelationshipsFounder, Vice President of Research & Development and Director--
James M. Coull Ph.D.No RelationshipsChief Technology Officer--
David Bohmert No RelationshipsGlobal Marketing Director--

AdvanDx, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Dennis H. Langer M.D., J.D. 223 RelationshipsAdvanDx, Inc.64
Henrik Stender Ph.D. 15 RelationshipsGfK Danmark A/S--
Thais T. Johansen MBA 9 RelationshipsBiolin Scientific Holding AB--
Jack T. Johansen Ph.D. 26 Relationships7TM Pharma A/S73
Hans Andreasson M.Sc., MBA 33 RelationshipsKA Intressenter AB60
View All Board Members

AdvanDx, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
354.7K
Bonus
241.4K
Total Short Term Compensation
444.3K
Total Value of Options
19.5M
Compensation as of Fiscal Year
AdvanDx, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Gilead Sciences Appoints Kennet Brysting as General Manager of Canadian Operations
February 20, 2017 1:37 PM ET
Kadmon Holdings Appoints Tasos G. Konidaris to Board of Directors
February 17, 2017 9:11 PM ET
Conatus Pharmaceuticals Inc. Announces Resignation of Charles J. Cashion as Senior Vice President, Finance, Chief Financial Officer and Secretary Effective from March 31, 2017
February 17, 2017 9:05 PM ET
Catabasis Pharmaceuticals, Inc. Announces Promotion of Ted Hibben to Chief Business Officer
February 17, 2017 1:00 PM ET
Botanix Pharmaceuticals Limited Announces Executive Changes
February 17, 2017 1:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AdvanDx, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.